MELK and lung adenocarcinoma: Tang et al. demonstrated that OTSSP167, as a potent inhibitor for MELK, blocks the G2/M phase cycle of lung adenocarcinoma (LUAD) cells by inhibiting MELK to trigger the pyroptosis [111].